LINDSEY MORROW: Open Payments
NPI 1386138295 · WEST MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,546 in 133 payments from 21 companies in 2025. Trend: 2023 $1,974 · 2024 $2,045 · 2025 $2,546
Food & beverage: $2,546
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $640 |
| ABBVIE INC. | 24 | $340 |
| Novo Nordisk Inc | 17 | $287 |
| PFIZER INC. | 15 | $239 |
| Amgen Inc. | 14 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $117 |
| Lilly USA, LLC | 6 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $105 |
| Abbott Laboratories | 4 | $86 |
| GlaxoSmithKline, LLC. | 4 | $78 |
Products named: BREZTRI, FARXIGA, VRAYLAR, NURTEC ODT, UBRELVY, Kerendia, Rybelsus, OTEZLA.
Industry payments across LA — which companies pay providers there.
